Leukotriene receptor antagonists role in recuding the cardiovascular and cerebrovascular risk: A case-control study in southern Spain
Background and Aims: Leukotriene receptor antagonists (LTRAs) are used in asthmatic patients, however different studies indicate that LTRAs can decrease intimal hyperplasia after vascular injury, and have a protective role in cerebral ischemia. The aim of our study was to assess the role of LTRAs in reducing myocardial infarction (MI) and ischemic stroke (IS) risk in patients from two Primary Health Care Centers of Granada.
Source: Atherosclerosis - Category: Cardiology Authors: M. Hoxha, V. Malaj, C. Rivilla Doce, A.B. Cavanillas Source Type: research
More News: Asthma | Cardiology | Cardiovascular | Health Management | Heart | Heart Attack | Ischemic Stroke | Spain Health | Stroke | Study